Furthermore, in patients with inflammatory, locally advanced breast cancer, bevacizumab was reported to induce apoptosis in tumor cells, along with its inhibitory effects on VEGFR2 activation and permeability [212]. This evidence concerns the gene KDR and breast cancer.